|
FBXO7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6251444634463E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62492241884138E-12 |
| Normal-vs-Stage2 |
8.9399998515205E-10 |
| Normal-vs-Stage3 |
1.67454938804212E-12 |
| Normal-vs-Stage4 |
7.92699239582362E-14 |
| Stage1-vs-Stage2 |
8.287800E-01 |
| Stage1-vs-Stage3 |
2.005600E-01 |
| Stage1-vs-Stage4 |
2.039300E-04 |
| Stage2-vs-Stage3 |
4.298400E-01 |
| Stage2-vs-Stage4 |
1.210110E-02 |
| Stage3-vs-Stage4 |
5.475700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
7.43849426498855E-15 |
| Normal-vs-Asian |
2.4621999994423E-08 |
| Caucasian-vs-AfricanAmerican |
8.732600E-01 |
| Caucasian-vs-Asian |
9.223900E-02 |
| AfricanAmerican-vs-Asian |
6.886400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.66133814775094E-16 |
| Normal-vs-Female |
1.62503344114384E-12 |
| Male-vs-Female |
2.880800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.65423230669148E-14 |
| Normal-vs-Extreme_Weight |
1.11022302462516E-16 |
| Normal-vs-Obese |
1.75881531561117E-12 |
| Normal-vs-Extreme_Obese |
3.75880004899187E-09 |
| Normal_Weight-vs-Extreme_Weight |
4.371600E-01 |
| Normal_Weight-vs-Obese |
1.559580E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.644400E-01 |
| Extreme_Weight-vs-Obese |
4.222400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.508000E-01 |
| Obese-vs-Extreme_Obese |
2.517000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.15909999998109E-06 |
| Normal-vs-Age(41-60Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(81-100Yrs) |
1.47739998013208E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.095400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.387000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.575200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.515800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.826000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.155400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63735691671718E-12 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
3.69779762365852E-11 |
| Normal-VS-Unclassified PRCC |
1.53699275529107E-12 |
| Type1 PRCC-VS-Type2 PRCC |
1.252330E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.504120E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.516200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.718000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.113600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.874200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62569957495862E-12 |
| Normal-vs-N1 |
5.77315972805081E-15 |
| Normal-vs-N2 |
1.90850000247877E-08 |
| N0-vs-N1 |
2.252800E-01 |
| N0-vs-N2 |
1.688580E-01 |
| N1-vs-N2 |
3.398000E-01 |
|
|
